|
||||
With the growing obesity epidemic, diabetes is becoming increasingly common. Accordingly, many Metabolic Diseases Institute scientists are working to understand the etiology of this disease with the ultimate goal of developing better treatments. For example, scientists are involved in preclinical and clinical research to study and optimize islet transplantation as a means of insulin replacement for people with diabetes. Such projects benefit from proximity to the University of Cincinnati Mouse Metabolic Phenotyping Center (MMPC). This Metabolic Diseases Institute-based facility provides comprehensive services for the characterization of mouse models pertaining to Type I and Type II diabetes. The University of Cincinnati Mouse Metabolic Phenotyping Center is supported by NIH grant DK059630
|
||||
|
Copyright Information © University of Cincinnati, 2010 |
||||